INTERCEPT Blood System for Platelets

PMA: BP140143
Device Generic Name: Pathogen Reduction System for Platelets
Tradename: INTERCEPT® Blood System for Platelets
Manufacturer: Cerus Corporation
Indications:

• The INTERCEPT Blood System for platelets is intended to be used for ex vivo preparation of pathogen-reduced Amicus apheresis platelet components suspended in 65% PAS-3/35% plasma, and Trima apheresis platelet components suspended in 100% plasma in order to reduce the risk of transfusion-transmitted infection (TTI), including sepsis, and as an alternative to gamma irradiation for prevention of transfusion-associated graft versus host disease (TA-GVHD).

Product Information

Supporting Documents

• Content current as of:

  12/20/2023

Source